| #1 | | | Istanbul, Turkey | | 33+ years | Lutetium-177 therapy, Actinium-225 therapy | Advanced prostate cancer with PSMA-targeted therapy | Offers specialized PSMA-targeted therapies with JCI accreditation and collaboration with Johns Hopkins Medicine. Doctors have 40+ publications in tumor biology and targeted therapy. | International Organization for Standardization, Joint Commission International |
| #2 | | | Istanbul, Turkey | | 25+ years | Lutetium-177 therapy, targeted drugs | Advanced or metastatic cancers | JCI-accredited oncology department with access to advanced targeted drugs and personalized therapy plans. Follows NCCN and ESMO protocols for precise treatment. | International Organization for Standardization, Joint Commission International |
| #3 | | | Istanbul, Turkey | | 15+ years | Lutetium-177 therapy | Advanced cancer cases requiring precision treatment | Specializes in Lutetium-177 therapy with a dedicated targeted therapy team led by an experienced oncologist. Offers precise diagnostics with 3T MRI and innovative Elekta Versa HD radiotherapy system. | International Organization for Standardization, Joint Commission International |
| #4 | | | Istanbul, Turkey | | 1+ year | Targeted therapy | — | — | — |
| #5 | | | Istanbul, Turkey | | 20+ years | Lutetium-177 therapy | Metastatic colorectal cancer | JCI-accredited hospital with specialized oncology team. Offers Lutetium-177 therapy for targeted cancer treatment. Doctors recommend personalized treatment plans based on molecular test results. | Joint Commission International , Turkish Medical Association (Türk Tabıplerı Bırliği) |
| #6 | | | Antalya , Turkey | | 26+ years | Targeted therapy, Lutetium-177 therapy | Metastatic and resistant cancers | Follows NCCN and ESMO protocols with a multidisciplinary team approach. Offers personalized treatment plans based on genetic testing. JCI-accredited hospital with 94% patient recommendation rate. | Joint Commission International |
| #7 | | | Istanbul, Turkey | | 14+ years | Lutetium-177 therapy | Advanced neuroendocrine tumors | Offers specialized Lutetium-177 therapy for targeted cancer treatment. JCI-accredited oncology hospital with PET-CT and advanced radiotherapy equipment including Trilogy and TrueBeam LINACs. | Joint Commission International , Patient choice in Pediatric Oncology & Hematology Oncology |
| #8 | | | Istanbul, Turkey | | 16+ years | Gastroscopy, Biopsy | — | — | Joint Commission International |
| #9 | | | Istanbul, Turkey | | 23+ years | Lutetium-177 therapy, monoclonal antibody therapy, immunotherapy | Pancreatic neuroendocrine tumors | Offers specialized Lutetium-177 therapy and personalized treatment plans based on genetic testing. Doctors have performed 1,100+ procedures with a focus on gastrointestinal cancers. | Turkish Medical Association, International Health Tourism Authorization Certificate |
| #10 | | | Istanbul, Turkey | | 76+ years | Targeted therapy, Bone marrow biopsy | — | — | International Organization for Standardization, Joint Commission International |